Elanco Animal Health Incorporated reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported sales was USD 1,113 million compared to USD 1,140 million a year ago. Net loss was USD 97 million compared to USD 323 million a year ago. Basic loss per share from continuing operations was USD 0.2 compared to USD 0.66 a year ago. Diluted loss per share from continuing operations was USD 0.2 compared to USD 0.66 a year ago.
For the full year, sales was USD 4,765 million compared to USD 3,273 million a year ago. Net loss was USD 472 million compared to USD 560 million a year ago. Basic loss per share from continuing operations was USD 0.97 compared to USD 1.27 a year ago. Diluted loss per share from continuing operations was USD 0.97 compared to USD 1.27 a year ago.